Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 29Ovarian Neoplasms 23Carcinoma, Ovarian Epithelial 18Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Neuroblastoma 13Central Nervous System Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Brain Neoplasms 8Brenner Tumor 7Adenocarcinoma, Bronchiolo-Alveolar 7Urinary Bladder Neoplasms 6Urethral Neoplasms 5Breast Neoplasms 5Astrocytoma 5Wilms Tumor 4Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Teratoma 3Radiation Injuries 3Optic Nerve Glioma 3Lymphoma 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Embryonal 3Carcinoma 3Thymoma 2

Interventions

Taxes 2Paclitaxel 2Doxorubicin 2Cisplatin 2pegfilgrastim 1nintedanib 1brivanib 1Radiotherapy 1Radiation 1Metformin 1Medroxyprogesterone Acetate 1Medroxyprogesterone 1Laparoscopy 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Carboplatin 1ALK1-Fc fusion protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Endometrial Adenocarcinoma × Carboplatin × Clear all
NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡